ERCC5 Antibody

1. This meta-analysis indicates that the XPG rs751402 polymorphism may be a risk factor for gastric cancer in the Chinese population. PMID: 29148016
2. There is a multifarious interaction between the DNA repair gene ERCC5 SNPs (rs2094258 and rs873601) and the metabolic gene GSTP1 rs1695, which may form the basis for various inter-individual susceptibilities to atrophic gastritis in Chinese population. PMID: 29434449
3. this meta-analysis shows that XPG gene polymorphisms are associated with lung cancer and gastric cancer PMID: 28416771
4. Nine case-control studies involving 3540 cases and 3953 controls were included in the meta-analysis, which revealed that the XPG rs751402 polymorphism is positively associated with GC risk and could be viewed as a risk factor of GC in three genetic models. The XPG gene rs751402 polymorphism is associated with an increased risk of GC in Chinese Han populations. This fi nding should be veri fi ed by larger studies. PMID: 28832189
5. In NBEC, T allele at SNP rs2296147 upregulates ERCC5. PMID: 27235448
6. XPG gene polymorphism rs751402 was associated with increased susceptibility to gastric cancer in Chinese populations (Meta-Analysis) PMID: 29049208
7. Overexpression of human XPG and FEN1 increases genome instability in U2OS cells PMID: 28704715
8. This study showed that XPG rs2296147 CT/TT variants conferred significant survival disadvantage in CRC patients in term of PFS. PMID: 26887052
9. These results indicated that none of the selected XPG polymorphism could significantly alter gastric cancer susceptibility alone. PMID: 27929383
10. meta-analysis suggested that the rs873601 polymorphism was significantly associated with overall cancer risk. The moderate effects of rs751402 and rs2296147 polymorphism on cancer susceptibility might be highly dependent on cancer type and ethnicity, respectively PMID: 28796034
11. XPG mRNA expression was not predictive of trabectedin efficacy as single agent in hormone-positive, HER-2-negative advanced breast cancer. PMID: 27266804
12. the XPG gene rs2094258 C>T polymorphism may contribute to neuroblastoma susceptibility. PMID: 27019310
13. No strong evidence was found to support the use of XPG polymorphisms as tumor response and prognostic factors of patients with NSCLC receiving a platinum-based treatment regimen--(REVIEW) PMID: 28314991
14. Xpg thus helps to adequately induce DNA damage responses after IR, thereby keeping the expansion of damaged cells under control. This represents a new function of Xpg in the response to IR, in addition to its well-characterized role in nucleotide excision repair. PMID: 27137888
15. Meta-analysis indicated that the ERCC1 rs3212986 polymorphism and 2 polymorphisms in ERCC2 gene (rs13181 and rs1799793) contributed to the susceptibility of glioma. However, no association was observed between glioma risk and ERCC1 rs11615, ERCC2 rs238406, and ERCC5 rs17655 polymorphisms. PMID: 28514298
16. The rs751402 C/T SNP T allele and the T/T genotype were associated with an increased risk of GCA in younger individuals (>61 years) (odds ratio [OR] = 1.33 and 1.77, 95% confidence interval [CI] = 1.00-1.76 and 1.12-3.30, respectively). The rs873601 G/A SNP was not associated with susceptibility to GCA. PMID: 27228234
17. The ERCC5 rs751402 gene polymorphism may influence the susceptibility to gastric cancer in the Chinese population. PMID: 27706622
18. we found that XPG rs2094258, rs751402, and rs17655 do not influence the development of breast cancer in a Chinese population PMID: 27323134
19. The results from this meta-analysis indicate that the XPG gene Asp1104His polymorphism is associated with lung cancer risk, especially in Asians. PMID: 27323149
20. ). In conclusion, we suggest that the rs2094258 and rs751402 polymorphisms of ERCC5 are not connected to the development of this disease under codominant, dominant, and recessive models. PMID: 27323158
21. The ERCC5 promoter polymorphisms at -763 and +25 may be important functional variants and predictors of clinical outcome of advanced colorectal cancer patients who received oxaliplatin chemotherapy. PMID: 27175691
22. our study suggests that the rs17655 polymorphism in XPG is associated with an increased risk of gastric cancer. The results of our findings should be further validated by further large sample size studies PMID: 27323165
23. we suggest that the ERCC5 rs751402 polymorphism is associated with development of gastric cancer PMID: 27323183
24. ERCC5 single nucleotide polymorphism rs751402 is associated with breast cancer characteristics and risk in the Han population of northwest China. PMID: 25644244
25. The results indicate that XPG rs873601G>A polymorphism may be associated with the risk of stomach cancer. PMID: 26820236
26. GG genotype of rs17655 was correlated with an increased risk of gastric cancer compared to the CC genotype. rs1047768 and rs751402 were not significantly correlated with gastric cancer risk. PMID: 27051028
27. Results show that XPG partners with BRCA1 and BRCA2 to maintain genomic stability through homologous recombination, and its loss causes DNA breaks, chromosome aberrations, and replication fork stalling. PMID: 26833090
28. ERCC5 rs17655 polymorphism might contribute to genetic susceptibility to colorectal cancer. PMID: 26225711
29. XRCC1 Arg399Gln and XPG His46His might significantly affect the clinical outcomes of platinum-based chemotherapy. PMID: 24737519
30. our study indicated that ERCC5 rs2094258 polymorphism may contribute to the risk of breast cancer. PMID: 26045839
31. XPG Asp1104His polymorphism is a risk factor for head and neck cancer susceptibility. PMID: 25987016
32. the rs2296147 and rs2094258 polymorphisms of XPG, could be used as surrogate markers, leading to individualization of non-small cell lung cancer treatment strategies. PMID: 25729984
33. CDT2 mediated XPG elimination from DNA damage sites clears the chromatin space needed for repair. PMID: 25483071
34. Individuals that harbor uORF1 of ERCC5 have a marked resistance to platinum-based agents PMID: 26338418
35. conclusion, our findings suggest that XPG Asp1104His polymorphism may increase the susceptibility of CRC, especially in Asian populations. PMID: 25332048
36. Meta-analysis suggests that XPF Arg415Gln polymorphism may be associated with decreased lung cancer risk and XPG Asp1104His may be a low-penetrant risk factor in some cancers development. PMID: 24802942
37. Our data broaden the reported clinical spectrum of ERCC5 mutations and provide further evidence of genotype-phenotype correlation with truncating mutations being associated with severe phenotypes. PMID: 24700531
38. A novel mutation in ERCC5, causative of a pellagra-like condition linked to xeroderma pigmentosum/Cockayne syndrome complex. PMID: 24354460
39. This meta-analysis suggested that the XPG Asp1104His polymorphism was a risk factor for melanoma susceptibility. PMID: 25231183
40. Results found that polymorphisms in XPG rs2296147 and CSB rs2228526 were significantly associated with prostate cancer susceptibility in the Chinese population analyzed. PMID: 24615090
41. our study indicated that XRCC1 Arg399Gln and ERCC5 His46His might significantly influence the response to chemotherapy PMID: 24782167
42. The XPC rs2228000 TT genotype is associated with shorter overall survival in gastric cancer. PMID: 24990617
43. Three SNPs of XPG, rs2296147T>C, rs2094258C>T and rs873601G>A, were genotyped. PMID: 23464443
44. study provided statistical evidence that XPG rs2296147T>C and rs873601G>A polymorphisms may be used as surrogate markers toward individualizing non-small cell lung cancer treatment strategies PMID: 24615519
45. ERCC5 rs17655 polymorphism may not contribute to genetic susceptibility for lung cancer PMID: 24596032
46. The XPG gene polymorphism was also related to bladder cancer yet it was prevalent in female non-smokers. PMID: 23246108
47. polymorphisms in rs1047768 C/T and rs2296147 C/T are associated with response to platinum-based chemotherapy in advanced non-small-cell lung cancer, and XPG polymorphisms could be predictive of prognosis. PMID: 23621222
48. Homozygoty for the wild-type Asp1104 SNP of the ERCC5 gene was found in 2 cases of relapsed osteosarcoma, who responded to trabectedin. PMID: 24192772
49. XPG Asp1104His polymorphism was not associated with bladder cancer risk. PMID: 24061640
50. XPG polymorphisms are associated with response to chemotherapy in osteosarcoma. PMID: 23886164

Show More

Hide All

HGNC: 3437

OMIM: 133530

KEGG: hsa:2073

STRING: 9606.ENSP00000347978

UniGene: Hs.258429